EUVIMEDEUVIMED entdecken
Crossref

SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma

Yohei Okuda, Junko Murai, Tsuyoshi Takashima, Naoya Sakamoto, Akihiro Yoshimura, Masaru Tani, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Toshihiro Uemura, Akinaru Yamamoto und 9 weitere

Anticancer Research · 2026

DOI: 10.21873/anticanres.18024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yohei Okuda und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The University of Osaka Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Granulocyte-Macrophage Colony-Stimulating Factor, Kidney Neoplasms, Macrophages.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellGranulocyte-Macrophage Colony-Stimulating FactorKidney NeoplasmsMacrophagesNuclear ProteinsHumansImmunotherapyCell Line, TumorTumor MicroenvironmentImmune Checkpoint InhibitorsTumor-Associated MacrophagesGene Expression Regulation, NeoplasticMacrophage Activation

Stichwörter der Autor:innen

CSF2GM-CSFICIM1 macrophageRCCRenal cell carcinomaSLFN11immune checkpoint inhibitor

Substanzen

Granulocyte-Macrophage Colony-Stimulating FactorSLFN11 protein, humanNuclear ProteinsImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Urology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
  • Department of Cell Growth and Tumor Regulation Proteo-Science Center, Ehime University, Ehime, Japan.
  • Department of Biochemistry and Molecular Genetics, Graduate School of Medicine, Ehime University, Ehime, Japan.
  • Department of Pathology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
  • Department of Molecular Pathology, Hyogo Medical University, Hyogo, Japan.
  • Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.

Zitieren

APA

Okuda, Y., Murai, J., Takashima, T., Sakamoto, N., Yoshimura, A., Tani, M., Horibe, Y., Liu, Y., Sassi, N., Oka, T., Uemura, T., Yamamoto, A., Yamamichi, G., Ishizuya, Y. U., Hayashi, T., Yamamoto, Y., Hatano, K., Kawashima, A., Morii, E., …, & Kato, T. (2026). SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.18024

Vancouver

Okuda Y, Murai J, Takashima T, Sakamoto N, Yoshimura A, Tani M, et al. SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma. Anticancer Research. 2026. doi:10.21873/anticanres.18024

BibTeX
@article{Okuda2026,
  author = {Okuda, Yohei and Murai, Junko and Takashima, Tsuyoshi and Sakamoto, Naoya and Yoshimura, Akihiro and Tani, Masaru and Horibe, Yuki and Liu, Yutong and Sassi, Nesrine and Oka, Toshiki and Uemura, Toshihiro and Yamamoto, Akinaru and Yamamichi, Gaku and Ishizuya, Y U and Hayashi, Takuji and Yamamoto, Yoshiyuki and Hatano, Koji and Kawashima, Atsunari and Morii, Eiichi and Nonomura, Norio and Kato, Taigo},
  title = {SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18024}
}
Kostenlos starten →